Toggle light / dark theme

Researchers at the University of North Carolina at Chapel Hill Department of Chemistry have engineered silicon nanowires that can convert sunlight into electricity by splitting water into oxygen and hydrogen gas, a greener alternative to fossil fuels.

Fifty years ago, scientists first demonstrated that liquid water can be split into oxygen and using electricity produced by illuminating a semiconductor electrode. Although hydrogen generated using is a promising form of clean energy, low efficiencies and have hindered the introduction of commercial solar-powered hydrogen plants.

An economic feasibility analysis suggests that using a slurry of electrodes made from nanoparticles instead of a rigid solar panel design could substantially lower costs, making solar-produced hydrogen competitive with fossil fuels. However, most existing particle-based light-activated catalysts, also referred to as photocatalysts, can absorb only , limiting their energy-conversion efficiency under solar illumination.

Autonomous aircraft have long been thought of as having the most potential, though not in the realm of glitzy people-carrying drones so much as the more sedate world of cargo. It’s here where the economic savings could be most significant. Large, long-range drones built specifically for cargo have the potential to be faster, cheaper and produce fewer CO2 emissions than conventional aircraft, enabling same-day shipping over very long distances. In fact, the “flying delivering van” is considered the holy grail by many cargo operators.

In this space there are a number of companies operating, and these include: ElroyAir (California, raised $56 million), hybrid electric, VTOL, so so therefore short range; Natilus (California, funding undisclosed) uses a blended wing body, and is a large, longer-term project entailing probably quite high costs in certification and production; and Beta (Vermont, $886 million raised), which is an electric VTOL.

Into this space, out of Bulgaria (but HQ’d in London), comes Dronamics. The startup has already attained a license to operate in Europe, and plans to run a “cargo drone airline” using drones built specifically for the purpose. Dronamics claims its flagship “Black Swan” model will be able to carry 350 kg (770 lb) at a distance of up to 2,500 km (1,550 miles) faster, cheaper and with less emissions than currently available options.

A second problem is the risk of technological job loss. This is not a new worry; people have been complaining about it since the loom, and the arguments surrounding it have become stylized: critics are Luddites who hate progress. Whither the chandlers, the lamplighters, the hansom cabbies? When technology closes one door, it opens another, and the flow of human energy and talent is simply redirected. As Joseph Schumpeter famously said, it is all just part of the creative destruction of capitalism. Even the looming prospect of self-driving trucks putting 3.5 million US truck drivers out of a job is business as usual. Unemployed truckers can just learn to code instead, right?

Those familiar replies make sense only if there are always things left for people to do, jobs that can’t be automated or done by computers. Now AI is coming for the knowledge economy as well, and the domain of humans-only jobs is dwindling absolutely, not merely morphing into something new. The truckers can learn to code, and when AI takes that over, coders can… do something or other. On the other hand, while technological unemployment may be long-term, its problematicity might be short-term. If our AI future is genuinely as unpredictable and as revolutionary as I suspect, then even the sort of economic system we will have in that future is unknown.

A third problem is the threat of student dishonesty. During a conversation about GPT-3, a math professor told me “welcome to my world.” Mathematicians have long fought a losing battle against tools like Photomath, which allows students to snap a photo of their homework and then instantly solves it for them, showing all the needed steps. Now AI has come for the humanities and indeed for everyone. I have seen many university faculty insist that AI surely could not respond to their hyper-specific writing prompts, or assert that at best an AI could only write a barely passing paper, or appeal to this or that software that claims to spot AI products. Other researchers are trying to develop encrypted watermarks to identify AI output. All of this desperate optimism smacks of nothing more than the first stage of grief: denial.

A couple minutes of your time for a little optimism.


Dr David Sinclair talks about no matter all the push backs and criticizes, he believes reverse aging therapy for human will be succeeded in this short clip.

David Sinclair is a professor in the Department of Genetics and co-director of the Paul F. Glenn Center for the Biology of Aging at Harvard Medical School, where he and his colleagues study sirtuins—protein-modifying enzymes that respond to changing NAD+ levels and to caloric restriction—as well as chromatin, energy metabolism, mitochondria, learning and memory, neurodegeneration, cancer, and cellular reprogramming.

In collaboration with the UC San Diego Center for Integrative Nutrition, the Berry Good Food Foundation convenes a panel of experts to discuss the rise of comprehensive medicine and nutritional healing to treat chronic disease and maintain general well-being. [6/2018] [Show ID: 33486]

Future Thought Leaders.
(https://www.uctv.tv/future-thought-leaders)

Explore More Public Affairs & Politics on UCTV
(https://www.uctv.tv/public-affairs)
Public Affairs UCTV goes beyond the headlines to explore economics, public policy, race, immigration, health policy and more. Hear directly from the researchers so you can be informed to make important decisions.

Explore More Health & Medicine on UCTV

Get Nebula using my link for 40% off an annual subscription: https://nebula.tv/medlifecrisis.

Watch this video ad-free: https://nebula.tv/videos/medlifecrisis-how-to-prevent-almost-all-disease.

Watch my conversation with another amazing guest where we discuss the effects and medical uses of recreational drugs https://nebula.tv/videos/medlife-crisis-the-worst-censorship…david-nutt.

It’s the best way to support this channel. Thank you!

So please for Tech news and views from the perspective of building a humane and sustainable economic system, check them all out!
And share them with your friends!

_________________________
Episode 24 discusses:
Ben Zion and Dr. Hale discuss the two most exceptional 21st century projects (beyond those to do with building a humane and sustainable economic system, which should have rightly been achieved in the 20th century) namely Universal Superlongevity and Human-Centered-Artificial-Superintelligence, and the noble work of Ageless Partners in the life extension arena.(continued in ep. 25)

Prof. Ian Hale, the autism author and broadcaster, is a member of the World Academy of Medical Science and Director of Research for Ageless Partners’ radical new rejuvenation project.

He’s an associate of both the Moscow Institute of Science & Technology & the Russian Academy of Science.

Forbes writer Kenrick Cai joins “Forbes Talks” to discuss his landmark report on how generative artificial intelligence will reshape the economy and the world.

Read the full story on Forbes: https://www.forbes.com/sites/kenrickcai/2023/02/02/things-yo…b4aebb5e31

Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more:

https://account.forbes.com/membership/?utm_source=youtube&ut…tdescript.

Apitherapy is an emerging field with the potential to impact the economic aspects of cancer research globally, particularly in under-resourced communities. To date, however, studies are yet to fully investigate the molecular mechanism of action of honeybee venom and melittin, and their consequent optimum usage in the oncology arena is yet to be comprehensively investigated, particularly for the treatment of breast cancer, the most commonly occurring cancer in women worldwide2. TNBCs and HER2-enriched tumors are highly aggressive breast cancer subtypes. TNBC is associated with the highest mortality and, despite frequent EGFR expression, commonly displays resistance to anti-EGFR therapies with high dependence on PI3K/Akt signaling for proliferation, survival, and chemotherapy resistance34.

Anti-HER2 therapies have substantially improved long-term survival in early-stage HER2-positive cancers, but the majority of late-stage patients eventually develop resistance and succumb to the disease33,35,36. Not only did we demonstrate selectivity of honeybee venom and melittin for malignant cells, but we also revealed higher potencies for these aggressive types of breast cancer.

Here, we show that honeybee venom and melittin suppress the ligand-induced phosphorylation of EGFR and HER2, dynamically modulating downstream signaling pathways in breast cancer cells. We propose that melittin directly or indirectly inhibits RTK dimerization. Melittin may also enter the cell to directly or indirectly modulate downstream signaling pathways25,60. Previous work has shown that melittin can be targeted to HER2-overexpressing cell lines using immunoliposomes bearing trastuzumab61. Here, we demonstrate that melittin alone selectively targets HER2-and EGFR-overexpressing breast cancer cells. Interestingly, melittin was more potently toxic to breast cancer cells compared to honeybee venom, warranting further investigation.